Table 1.
Baseline characteristics of the study participants
| Lean mass |
Fat mass |
Total (n=18) | |||
|---|---|---|---|---|---|
| High level group (n=9) | Low level group (n=9) | High level group (n=9) | Low level group (n=9) | ||
| Age (y) | 45±11.1 | 43±13.4 | 44±13.7 | 44±11.0 | 44±12.0 |
| Recipient's male sex (%) | 100.0 | 55.6 | 88.9 | 66.7 | 77.8 |
| Deceased donor (%) | 55.6 | 22.2 | 33.3 | 44.4 | 38.9 |
| Donor's age (y) | 31±7.3 | 33±9.3 | 35±8.6 | 29±6.8 | 32±8.2 |
| Donor's male sex (%) | 75.0 | 55.6 | 50.0 | 77.8 | 64.7 |
| HLA mismatching | 3±1.8 | 3±1.9 | 3±1.8 | 3±1.9 | 3±1.8 |
| Serum biochemical marker | |||||
| Creatinine (mg/dL) | 1.3±0.17 | 1.2±0.29 | 1.3±0.17 | 1.2±0.29 | 1.2±0.23 |
| Glucose (mg/dL) | 107±18.9 | 120±83.4 | 105±20.0 | 121±82.9 | 113±59.1 |
| Bilirubin (mg/dL) | 1.0±0.41 | 0.7±0.24 | 1.0±0.43 | 0.7±0.24 | 0.9±0.36 |
| Total cholesterol (mg/dL) | 168±37.6 | 164±28.0 | 175±25.8 | 158±37.0 | 166±32.2 |
| Triglyceride (mg/dL) | 174±53.8 | 140±42.9 | 168±44.8 | 146±55.9 | 157±50.4 |
| HDL cholesterol (mg/dL) | 46±9.2 | 51±15.1 | 48±8.8 | 48±15.9 | 48±12.5 |
| LDL cholesterol (mg/dL) | 101±36.0 | 95±25.3 | 105±30.1 | 90±30.4 | 98±30.3 |
| High-sensitivity CRP (mg/dL)⁎ | 0.01 (0.01–0.08) | 0.06 (0.01–0.08) | 0.01 (0.01–0.04) | 0.06 (0.01–1.00) | 0.01 (0.01–0.07) |
| From operation to test (mo)⁎ | 40 (10–57) | 56 (34–100) | 26 (10–61) | 56 (43–99) | 46 (16–74) |
CRP, C-reactive protein; HDL, high-density lipoprotein; HLA, human leukocyte antigen; LDL, low-density lipoprotein.
⁎
Data are expressed as the median (interquartile range) when the distribution of data was skewed.